Frequency and Phenotype of EHV-1 Specific, IFN-gamma Synthesising Lymphocytes in Ponies: the Effects of Age, Pregnancy and Infection
Overview
Authors
Affiliations
Equine herpesvirus-1 (EHV-1) infects horses, causing acute respiratory disease, neurological signs, and is also a leading cause of abortion. Protection from EHV-1 infection and disease depends on both humoral (virus neutralising antibody) and cellular (mainly cytotoxic T lymphocytes, CTL) immune responses. CTL activity after EHV-1 infection has been extensively investigated and is closely associated with an alternative measure of cell mediated immunity (CMI), interferon-gamma (IFN-gamma) synthesis. This study investigates EHV-1-specific IFN-gamma synthesising cells in potentially immunocompromised horses; foals, pregnant mares and aged animals, after field or experimental infection with EHV-1. In foals and pregnant mares, the kinetics after experimental infection were similar and the phenotype of IFN-gamma+ synthesising cells after EHV-1 stimulation was mainly CD8alpha+. In contrast, in samples collected from primed healthy ponies exposed to EHV-1 several months previously or in old ponies (28 years old), the majority of EHV-1-specific IFN-gamma+ lymphocytes expressed a CD5+, CD8alpha- phenotype. This study highlights the complexity of the relationship between EHV-1, a common pathogen in horses, and the virus-specific cellular immune response as measured using IFN-gamma synthesis.
Characterization of Nasal Mucosal T Cells in Horses and Their Response to Equine Herpesvirus Type 1.
Holmes C, Wagner B Viruses. 2024; 16(10).
PMID: 39459849 PMC: 11512333. DOI: 10.3390/v16101514.
Zarski L, Weber P, Lee Y, Soboll Hussey G Pathogens. 2021; 10(1).
PMID: 33430330 PMC: 7825769. DOI: 10.3390/pathogens10010043.
Schnabel C, Babasyan S, Rollins A, Freer H, Wimer C, Perkins G J Virol. 2019; 93(22).
PMID: 31462575 PMC: 6819910. DOI: 10.1128/JVI.01011-19.
Wimer C, Schnabel C, Perkins G, Babasyan S, Freer H, Stout A PLoS One. 2018; 13(11):e0206679.
PMID: 30440016 PMC: 6237298. DOI: 10.1371/journal.pone.0206679.
Hue E, Richard E, Fortier C, Fortier G, Paillot R, Raue R Vaccines (Basel). 2017; 5(3).
PMID: 28925977 PMC: 5620559. DOI: 10.3390/vaccines5030028.